BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1938 related articles for article (PubMed ID: 25079328)

  • 21. Systematically assessing microbiome-disease associations identifies drivers of inconsistency in metagenomic research.
    Tierney BT; Tan Y; Yang Z; Shui B; Walker MJ; Kent BM; Kostic AD; Patel CJ
    PLoS Biol; 2022 Mar; 20(3):e3001556. PubMed ID: 35235560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals.
    Liu J; Wu D; Ahmed A; Li X; Ma Y; Tang L; Mo D; Ma Y; Xin Y
    Curr Microbiol; 2012 Jul; 65(1):7-13. PubMed ID: 22484797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Landscape of Genetic Content in the Gut and Oral Human Microbiome.
    Tierney BT; Yang Z; Luber JM; Beaudin M; Wibowo MC; Baek C; Mehlenbacher E; Patel CJ; Kostic AD
    Cell Host Microbe; 2019 Aug; 26(2):283-295.e8. PubMed ID: 31415755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering the composition of microbial community structure and metagenomics among three gut locations in pigs with distinct fatness.
    Yang H; Huang X; Fang S; Xin W; Huang L; Chen C
    Sci Rep; 2016 Jun; 6():27427. PubMed ID: 27255518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
    Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
    Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.
    Sedighi M; Razavi S; Navab-Moghadam F; Khamseh ME; Alaei-Shahmiri F; Mehrtash A; Amirmozafari N
    Microb Pathog; 2017 Oct; 111():362-369. PubMed ID: 28912092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
    Bajaj JS; Cox IJ; Betrapally NS; Heuman DM; Schubert ML; Ratneswaran M; Hylemon PB; White MB; Daita K; Noble NA; Sikaroodi M; Williams R; Crossey MM; Taylor-Robinson SD; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G951-7. PubMed ID: 25258407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.
    Scher JU; Ubeda C; Artacho A; Attur M; Isaac S; Reddy SM; Marmon S; Neimann A; Brusca S; Patel T; Manasson J; Pamer EG; Littman DR; Abramson SB
    Arthritis Rheumatol; 2015 Jan; 67(1):128-39. PubMed ID: 25319745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease.
    De Cruz P; Prideaux L; Wagner J; Ng SC; McSweeney C; Kirkwood C; Morrison M; Kamm MA
    Inflamm Bowel Dis; 2012 Feb; 18(2):372-90. PubMed ID: 21604329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.
    Macnaughtan J; Jalan R
    Am J Gastroenterol; 2015 Oct; 110(10):1399-410; quiz 1411. PubMed ID: 26416191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease.
    Greenblum S; Turnbaugh PJ; Borenstein E
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):594-9. PubMed ID: 22184244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
    Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
    Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metagenome-wide association studies: fine-mining the microbiome.
    Wang J; Jia H
    Nat Rev Microbiol; 2016 Aug; 14(8):508-22. PubMed ID: 27396567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data.
    Han W; Ye Y
    Pac Symp Biocomput; 2019; 24():236-247. PubMed ID: 30864326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients.
    Wellhöner F; Döscher N; Tergast TL; Vital M; Plumeier I; Kahl S; Potthoff A; Manns MP; Maasoumy B; Wedemeyer H; Cornberg M; Pieper DH; Heidrich B
    Scand J Gastroenterol; 2019 Aug; 54(8):1033-1041. PubMed ID: 31361979
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis.
    Chen Y; Qin N; Guo J; Qian G; Fang D; Shi D; Xu M; Yang F; He Z; Van Nostrand JD; Yuan T; Deng Y; Zhou J; Li L
    BMC Genomics; 2014 Sep; 15(1):753. PubMed ID: 25179593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The gut microbiota in sickness and health].
    Lankelma JM; Nieuwdorp M; de Vos WM; Wiersinga WJ
    Ned Tijdschr Geneeskd; 2014; 157():A5901. PubMed ID: 24780568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gut microbiome in atherosclerotic cardiovascular disease.
    Jie Z; Xia H; Zhong SL; Feng Q; Li S; Liang S; Zhong H; Liu Z; Gao Y; Zhao H; Zhang D; Su Z; Fang Z; Lan Z; Li J; Xiao L; Li J; Li R; Li X; Li F; Ren H; Huang Y; Peng Y; Li G; Wen B; Dong B; Chen JY; Geng QS; Zhang ZW; Yang H; Wang J; Wang J; Zhang X; Madsen L; Brix S; Ning G; Xu X; Liu X; Hou Y; Jia H; He K; Kristiansen K
    Nat Commun; 2017 Oct; 8(1):845. PubMed ID: 29018189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.
    Bajaj JS; Betrapally NS; Hylemon PB; Thacker LR; Daita K; Kang DJ; White MB; Unser AB; Fagan A; Gavis EA; Sikaroodi M; Dalmet S; Heuman DM; Gillevet PM
    Sci Rep; 2015 Dec; 5():18559. PubMed ID: 26692421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 97.